Engineering and Development

Management and Executive

Product Management

Chief Executive Officer (CEO)

Chief Financial Officer

Kuehn Law Encourages Investors of Tempus AI, Inc. to Contact Law Firm

Tempus AI Adds Digital Pathology to Cancer Portfolio With Paige Acquisition

Genetic Testing Market to Soar to $54.2B by 2033, Driven by Personalized Medicine and Tech Innovation

Tempus AI, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. August 12, 2025 Deadline to file Lead Plaintiff Motion

Genomic Science Liaison II, Rare Disease

Ambry Genetics is a CAP-accredited and CLIA-licensed molecular genetics laboratory dedicated to improving health through genetic understanding. They are seeking a Genomic Science Liaison II who will engage healthcare professionals, manage territories, and implement data-driven strategies to promote clinical genomic testing solutions, particularly for rare diseases.

Genomic Science Liaison II, Rare Disease (North region): Remote, USA

Senior Talent Acquisition Partner

Genomic Science Liaison 

Genomic Science Liaison II

Genomic science liaison

Sign up with Google

Sign in with Google